D: Filing D
NEUROSENSE THERAPEUTICS LTD C/WTS (TO PUR COM) | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Ariel Gordon.(6.9%)
NEUROSENSE THERAPEUTICS LTD C/WTS (TO PUR COM) | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Alon Ben-Noon(19.98%)
NEUROSENSE THERAPEUTICS LTD C/WTS (TO PUR COM) | D: Filing D
NEUROSENSE THERAPEUTICS LTD C/WTS (TO PUR COM) | SC 13G/A: Statement of acquisition of beneficial ownership by individuals(Amendment)-Alon Ben-Noon(25.77%)
NEUROSENSE THERAPEUTICS LTD C/WTS (TO PUR COM) | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Ariel Gordon.(8.92%)
NEUROSENSE THERAPEUTICS LTD C/WTS (TO PUR COM) | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-E Europe Limited(0%)
NEUROSENSE THERAPEUTICS LTD C/WTS (TO PUR COM) | SC 13G: Statement of acquisition of beneficial ownership by individuals-Real Property International Limited(3.84%)
NEUROSENSE THERAPEUTICS LTD C/WTS (TO PUR COM) | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions
NEUROSENSE THERAPEUTICS LTD C/WTS (TO PUR COM) | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions
NEUROSENSE THERAPEUTICS LTD C/WTS (TO PUR COM) | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions
No Data